MedTrace Logo

Comparison of CPAP and Gamow Bag Ventilation to Treat HAPE

NCT04710953 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-01-15

No results posted yet for this study

Summary

High altitude pulmonary edema (HAPE) is mostly treated with supplemental oxygen, nifedipine 30mg twice a day, rest, limiting cold exposure and descent (simulated or actual) Gamow Bag provides simulated descent and buy time for actual descent. CPAP is claimed to be effective in many case reports to treat HAPE temporarily until actual descent is taken place. This study aims to evaluate the role of CPAP in treating HAPE at those high altitude stations where Gamow bag is not available and immediate descent is not possible.

Conditions

  • High Altitude Pulmonary Edema

Interventions

DEVICE

Continuous positive airway pressure machine

CPAP device set at 6-8cmH2O for several hours

Sponsors & Collaborators

  • Pak Emirates Military Hospital

    collaborator OTHER

  • HALMARC

    collaborator UNKNOWN

  • sultan mehmood kamran

    lead OTHER

Principal Investigators

  • Imran Fazal, FCPS · Pak Emirates Military Hospital Rawalpindi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-30
Primary Completion
2022-04-30
Completion
2022-04-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04710953 on ClinicalTrials.gov